Michael William Pride is a notable inventor based in Staten Island, NY (US), recognized for his significant contributions to the field of immunology and vaccine development. He holds a total of 10 patents, showcasing his innovative approach to creating effective immunogenic compositions.

Latest Patents

Among his latest patents, one focuses on immunogenic compositions for use in pneumococcal vaccines. This invention aims to provide protection against serogroup 18 while minimizing the number of conjugates used. The compositions are designed for vaccination of human subjects, particularly infants and the elderly, against pneumococcal infections. Another patent involves immunogenic compositions comprising conjugated capsular saccharide antigens, which are essential for developing vaccines that target serotypes not found in existing products like PREVNAR® and SYNFLORIX®. These innovations are crucial for enhancing vaccine efficacy and safety.

Career Highlights

Michael has worked with prominent companies in the pharmaceutical industry, including Pfizer Corporation and Wyeth Holdings Corporation. His experience in these organizations has significantly influenced his research and development efforts in vaccine technology.

Collaborations

Throughout his career, Michael has collaborated with esteemed colleagues such as David Cooper and Kathrin Ute Jansen. These partnerships have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Michael William Pride's work in the field of pneumococcal vaccines exemplifies his dedication to improving public health through innovative solutions. His patents reflect a commitment to advancing vaccine technology and protecting vulnerable populations.

This text is generated by artificial intelligence and may not be accurate.